ReviewDrug safety2004
Benefit-risk assessment of rofecoxib in the treatment of osteoarthritis.
Helmut Schmidt et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ReviewDrug safety2004
Helmut Schmidt et al.PubMed ↗Publisher ↗
No numbers read from the abstract.